Fiercepharma has;
WSJ: J&J Federal Risperdal Deal Hung Up On Language Over Breasts
Feds want side effects data in, J&J wants to avoid adding to civil litigation troubles
May 10, 2013 | By Eric Palmer
Johnson & Johnson ($JNJ) has been negotiating terms of a multi-billion dollar settlement over aggressive marketing of its antipsychotic drug Risperdal with federal authorities for at least two years, and now it is hung on talk over breasts, The Wall Street Journal says.
The newspaper, once again citing sources, says the feds want J&J to acknowledge it downplayed data on a side effect that bumped up levels of hormone that stimulates breast development and milk production in women. J&J does not want to include language that might be used in civil lawsuits that make the same claim. The company has already settled cases that claim the drug caused boys to develop breasts but faces dozens more and unknown levels of potential awards. No comments were offered up from either side.
The Risperdal saga has been full of twists and turns, as any long-running investigation tends to be. The feds have been looking into J&J's marketing of the antipsychotic pill since 2004. In the meantime, several of its Big Pharma rivals have inked their own marketing settlements, including Pfizer's ($PFE) $2.3 billion Bextra deal and last year's GlaxoSmithKline ($GSK) $3 billion settlement, which covers off-label and safety-related claims. Last year officials were reportedly ready to settle on a $1 billion payment from J&J, but higher-ups wanted to hold out for more. Since then, The Wall Street Journal has cited sources putting the price at $2.2 billion.
Last summer J&J reached a settlement with 36 states and the District of Columbia over the marketing of Risperdal that topped $180 million. It also has settled a number of civil suits that make the claim about breast development. It hammered out deals on 5 cases last fall, and so managed to avoid testimony from former FDA Commissioner David Kessler. He was slated to testify in one case that he believed J&J's Janssen unit not only violated the Food, Drug, and Cosmetic Act by promoting Risperdal off-label, but that its marketing to children was "most concerning."
Special Report: Pharma's Top 11 Marketing Settlements
Related Articles:
WSJ: Feds want $1B settlement in J&J Risperdal probe
J&J close to $1.5B-plus Risperdal settlement, but not there yet
J&J aims to block ex-FDA chief's testimony in Risperdal case
J&J to pay states $181M to resolve Risperdal cases
Thank You FiercePharma and Mr Palmer
Kevin, M.D.: ” a new low, drug marketing on children’s toys.”Pharmalot: “Keep in mind that, as of last October, Risperdal is approved for kids showing autistic symptoms. So perhaps we should expect to see all manner of playthings with the drug’s brand name. How about a ‘Doctor Barbie’ with Risperdal samples?”Medgadget: “Drugs are booooring… We do like the Legos though.”
94% Of Drug Adverse Reactions Are Never Reported To Govt Regulators: Study
"Contains no active drug."
Why would the Docs the sales bling/popcorn was handed out to need to be told the popcorn contains no active drug?
Isn't Risperdal supposed to induce 'Mental Health'? That IS what it's sold for. Wouldn't the Docs pushing this drug want to be 'Mentally Healthy" themselves, or do you think, Just Maybe, they know Damn Well Better than to Ingest the stuff themselves?
And the Federal buy out/parking ticket is hanging up.
Legos and Popcorn.
The newspaper, once again citing sources, says the feds want J&J to acknowledge it downplayed data on a side effect that bumped up levels of hormone that stimulates breast development and milk production in women. J&J does not want to include language that might be used in civil lawsuits that make the same claim. The company has already settled cases that claim the drug caused boys to develop breasts but faces dozens more and unknown levels of potential awards. No comments were offered up from either side.
The Risperdal saga has been full of twists and turns, as any long-running investigation tends to be. The feds have been looking into J&J's marketing of the antipsychotic pill since 2004. In the meantime, several of its Big Pharma rivals have inked their own marketing settlements, including Pfizer's ($PFE) $2.3 billion Bextra deal and last year's GlaxoSmithKline ($GSK) $3 billion settlement, which covers off-label and safety-related claims. Last year officials were reportedly ready to settle on a $1 billion payment from J&J, but higher-ups wanted to hold out for more. Since then, The Wall Street Journal has cited sources putting the price at $2.2 billion.
Last summer J&J reached a settlement with 36 states and the District of Columbia over the marketing of Risperdal that topped $180 million. It also has settled a number of civil suits that make the claim about breast development. It hammered out deals on 5 cases last fall, and so managed to avoid testimony from former FDA Commissioner David Kessler. He was slated to testify in one case that he believed J&J's Janssen unit not only violated the Food, Drug, and Cosmetic Act by promoting Risperdal off-label, but that its marketing to children was "most concerning."
Special Report: Pharma's Top 11 Marketing Settlements
Related Articles:
WSJ: Feds want $1B settlement in J&J Risperdal probe
J&J close to $1.5B-plus Risperdal settlement, but not there yet
J&J aims to block ex-FDA chief's testimony in Risperdal case
J&J to pay states $181M to resolve Risperdal cases
Thank You FiercePharma and Mr Palmer
http://medgadget.com/2007/05/risperdal_legos.html
Promotional materials for Risperdal (risperidone), an atypical antipsychotic medication, is drawing ire from some in the medical blogosphere.
Promotional materials for Risperdal (risperidone), an atypical antipsychotic medication, is drawing ire from some in the medical blogosphere.
Kevin, M.D.: ” a new low, drug marketing on children’s toys.”Pharmalot: “Keep in mind that, as of last October, Risperdal is approved for kids showing autistic symptoms. So perhaps we should expect to see all manner of playthings with the drug’s brand name. How about a ‘Doctor Barbie’ with Risperdal samples?”Medgadget: “Drugs are booooring… We do like the Legos though.”
Risperidone | Reported By | ||||||
Adverse Reaction | Cases | MD | CN | OT | PH | LW | NR |
Suicidal Ideations | 142 | 86 | 63 | 51 | 3 | 2 | 10 |
Attempted Suicides | 248 | 248 | 25 | 53 | 17 | 6 | 11 |
Completed Suicides | 107 | 84 | 12 | 37 | 9 | 4 | 4 |
Deaths Not From Suicide | 900 | 788 | 135 | 357 | 75 | 48 | 33 |
Homicidal Ideations | 16 | 16 | 2 | 14 | 0 | 0 | 0 |
Homicides | 14 | 14 | 3 | 1 | 2 | 1 | 1 |
Hypomania/Mania | 31 | 18 | 8 | 9 | 0 | 0 | 5 |
Heart Disease | 318 | 262 | 37 | 90 | 44 | 8 | 18 |
Movement Disorders | 964 | 535 | 226 | 355 | 132 | 37 | 76 |
Birth Defects | 50 | 37 | 3 | 24 | 6 | 0 | 3 |
Premature Births | 11 | 9 | 0 | 6 | 0 | 0 | 0 |
Prenatal/Neonatal Deaths | 45 | 34 | 12 | 22 | 4 | 0 | 0 |
94% Of Drug Adverse Reactions Are Never Reported To Govt Regulators: Study
"Contains no active drug."
Why would the Docs the sales bling/popcorn was handed out to need to be told the popcorn contains no active drug?
Isn't Risperdal supposed to induce 'Mental Health'? That IS what it's sold for. Wouldn't the Docs pushing this drug want to be 'Mentally Healthy" themselves, or do you think, Just Maybe, they know Damn Well Better than to Ingest the stuff themselves?
And the Federal buy out/parking ticket is hanging up.
Legos and Popcorn.
As men get more seasoned, they deliver less testosterone. Likewise, more established men have a tendency to have more muscle to fat ratio ratios, and this can result in more estrogen to be created. These progressions in hormone levels can prompt overabundance bosom tissue development.
ReplyDeletethanks
smith